APPLIED DNA SCIENCES INC's ticker is APDNW and the CUSIP is 03815U110. A total of 7 filers reported holding APPLIED DNA SCIENCES INC in Q4 2018. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2019 | $0 | – | 31,407 | -66.7% | 0.00% | – |
| Q2 2019 | $0 | -100.0% | 94,221 | +200.0% | 0.00% | -100.0% |
| Q1 2019 | $1,000 | – | 31,407 | 0.0% | 0.00% | – |
| Q4 2018 | $0 | -100.0% | 31,407 | 0.0% | 0.00% | -100.0% |
| Q3 2018 | $7,000 | -22.2% | 31,407 | 0.0% | 0.01% | +9.1% |
| Q2 2018 | $9,000 | +12.5% | 31,407 | 0.0% | 0.01% | 0.0% |
| Q1 2018 | $8,000 | – | 31,407 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GENERAL AMERICAN INVESTORS CO INC | 281,409 | $472,000 | 0.04% |
| Ionic Capital Management LLC | 349,859 | $587,000 | 0.04% |
| Benchmark Capital Advisors | 10,000 | $17,000 | 0.01% |
| Creative Planning | 70,600 | $119,000 | 0.00% |
| BLACKROCK ADVISORS LLC | 36,771 | $62,000 | 0.00% |
| NEXT Financial Group, Inc | 1,000 | $1,000 | 0.00% |